载脂蛋白B100(APOB100)多克隆抗体
Polyclonal Antibody to Apolipoprotein B100 (APOB100)
Apo-B100
- 编号PAA603Hu02
 - 物种Homo sapiens (Human,人)相同的名称,不同的物种。
 - 来源多抗制备
 - 宿主兔
 - 效价-
 - Ig类型IgG
 - 纯化方式抗原特异性亲和纯化
 - 标记物无标记物
 - 免疫原RPA603Hu01-载脂蛋白B100(APOB100)重组蛋白
 - 缓冲液成份10mM tris, 150mM NaCl, pH8.2, containing 0.05% Proclin-300.
 - 性状液体
 - 浓度0.5mg/ml
 - 且适物种-
 - 应用ICC/IF
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载英文说明书 中文说明书
 - 规格20µl100µl200µl1ml10ml
 - 价格¥ 448¥ 1046¥ 1494¥ 3735¥ 14940
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
该抗体是针对APOB100的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别APOB100。
用法
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) | 
| NPA603Hu01 | 载脂蛋白B100(APOB100)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA603Hu01 | 载脂蛋白B100(APOB100)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA603Hu01 | 载脂蛋白B100(APOB100)多克隆抗体 | WB; IHC; ICC; IP. | 
| PAA603Hu02 | 载脂蛋白B100(APOB100)多克隆抗体 | ICC/IF | 
| LAA603Hu71 | 载脂蛋白B100(APOB100)多克隆抗体(生物素标记) | IHC | 
| MAA603Hu23 | 载脂蛋白B100(APOB100)单克隆抗体 | WB; IHC | 
| MAA603Hu24 | 载脂蛋白B100(APOB100)单克隆抗体 | WB | 
| MAA603Hu25 | 载脂蛋白B100(APOB100)单克隆抗体 | WB | 
| MAA603Hu29 | 载脂蛋白B100(APOB100)单克隆抗体 | WB | 
| MAA603Hu27 | 载脂蛋白B100(APOB100)单克隆抗体 | IHC | 
| MAA603Hu21 | 载脂蛋白B100(APOB100)单克隆抗体 | WB; IHC | 
| MAA603Hu22 | 载脂蛋白B100(APOB100)单克隆抗体 | WB; IHC | 
| SEA603Hu | 载脂蛋白B100(APOB100)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| SCA603Hu | 载脂蛋白B100(APOB100)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| LMA603Hu | 载脂蛋白B100(APOB100)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
参考文献
| 杂志 | 参考文献 | 
| PLoS One | Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropoyl-β-Cyclodextrin[Plosone: 0018033] | 
| Autonomic Neuroscience | Chemical sympathectomy induces arterial accumulation of native and oxidized LDL in hypercholesterolemic rats[ScienceDirect: S1566070211004152] | 
| Toxicology | iTRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure[ScienceDirect: S0300483X11004628] | 
| Atherosclerosis | Up-reCavia (Guinea pig )lation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations [Pubmed:26978583] | 
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509] | 
| molecular nutrition & food research | Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr-/- mice with diet-induced insulin resistance.[pubmed:27928899] | 
| PROTEOMICS - Clinical Applications | Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients.[pubmed:26680509] | 
| Biosci Biotechnol Biochem. | Choline and betaine ameliorate liver lipid accumulation induced by vitamin B6 deficiency in rats.[pubmed:27696964] | 
| Journal of Nutritional Science and Vitaminology | Accumulation of Liver Lipids Induced by Vitamin B6 Deficiency Was Effectively Ameliorated by Choline and, to a Lesser Extent, Betaine[Pubmed: 30814419] | 
| ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY | Zygophyllum album saponins prevent atherogenic effect induced by deltamethrin via attenuating arterial accumulation of native and oxidized LDL in rats[Pubmed: 32105945] | 
| Ecotoxicol Environ Saf | Permethrin induced arterial retention of native and oxidized LDL in rats by promoting inflammation, oxidative stress and affecting LDL receptors, and collagen …[Pubmed: 32911180] | 
| Nat Commun | GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity[34853313] | 
| Clinical Nutrition | Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or Type 2 diabetes[34656950] | 
| Nano Research | Immunomodulatory hybrid bio-nanovesicle for self-promoted photodynamic therapy[] | 



